ARS Pharmaceuticals Inc

SPRY NASDAQ Santé & Biotech États-Unis US82835W1080
9.88 $
4.11 %

ARS Pharmaceuticals Inc se concentre sur le développement de solutions pour la gestion des réactions allergiques sévères.

Performance & Momentum

6 Months 6.35 %
1 Year 33.40 %
3 Years 53.32 %
5 Years 71.14 %

Similar stocks to ARS Pharmaceuticals Inc

Anantys Community

Be the first to share your analysis on ARS Pharmaceuticals Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases